TransMedics Book Value Per Share from 2010 to 2024

TMDX Stock

USD 78.58 2.54 3.34%

TransMedics Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of TransMedics Group according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

4.21934466

Current Value

4.43

Quarterly Volatility

4.18954977

Credit Downgrade

Yuan Drop

Covid

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Selling General Administrative of 125.5 M or Research Development of 22.2 M, as well as many indicators such as Price To Sales Ratio of 10.09, Dividend Yield of 0.0 or PTB Ratio of 19.64. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.

Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of TransMedics Group over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. TransMedics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 6.25 X

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

TransMedics Book Value Per Share Regression Statistics

	Arithmetic Mean	2.65
	Geometric Mean	3.48
	Coefficient Of Variation	158.23
	Mean Deviation	2.32
	Median	3.85
	Standard Deviation	4.19
	Sample Variance	17.55
	Range	17.9932
	R-Value	0.05
	Mean Square Error	18.86
	R-Squared	0
	Significance	0.87
	Slope	0.04
	Total Sum of Squares	245.73

TransMedics Book Value Per Share History

	2024	4.43
	2023	4.22
	2022	6.34
	2021	2.46
	2019	4.21
	2018	-0.25
	2017	-11.65

Other Fundumenentals of TransMedics Group

Tangible Book Value Per Share

TransMedics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.7	0.81	-0.75	0.86	0.98	-0.37	0.94	1.0	0.61	0.91	0.99	0.96	0.64	0.59	0.94	0.96	-0.91	0.99	0.14	-0.62	0.78	-0.91
Total Stockholder Equity	0.7		0.93	-0.74	0.47	0.59	-0.08	0.53	0.73	0.96	0.83	0.7	0.52	0.16	0.94	0.52	0.86	-0.49	0.77	0.62	-0.91	0.92	-0.49
Net Tangible Assets	0.81	0.93		-0.75	0.58	0.71	-0.05	0.66	0.85	0.86	0.89	0.81	0.65	0.27	0.8	0.65	0.9	-0.62	0.87	0.4	-0.92	0.95	-0.62
Retained Earnings	-0.75	-0.74	-0.75		-0.69	-0.66	0.01	-0.66	-0.78	-0.79	-0.82	-0.73	-0.6	-0.27	-0.77	-0.59	-0.82	0.58	-0.77	-0.45	0.77	-0.82	0.58
Accounts Payable	0.86	0.47	0.58	-0.69		0.9	-0.32	0.87	0.84	0.44	0.75	0.85	0.88	0.75	0.5	0.87	0.81	-0.85	0.81	0.2	-0.47	0.53	-0.85
Long Term Debt	0.98	0.59	0.71	-0.66	0.9		-0.42	0.97	0.96	0.49	0.83	0.97	1.0	0.77	0.52	0.97	0.91	-0.95	0.95	0.11	-0.5	0.66	-0.95
Short Term Investments	-0.37	-0.08	-0.05	0.01	-0.32	-0.42		-0.46	-0.34	0.02	-0.39	-0.45	-0.44	-0.14	0.03	-0.42	-0.28	0.41	-0.34	0.4	-0.21	-0.13	0.41
Total Liab	0.94	0.53	0.66	-0.66	0.87	0.97	-0.46		0.92	0.45	0.81	0.94	0.97	0.74	0.47	0.94	0.87	-0.92	0.92	0.07	-0.47	0.63	-0.92
Total Current Assets	1.0	0.73	0.85	-0.78	0.84	0.96	-0.34	0.92		0.65	0.93	0.99	0.93	0.59	0.63	0.91	0.96	-0.89	1.0	0.16	-0.67	0.83	-0.89
Common Stock	0.61	0.96	0.86	-0.79	0.44	0.49	0.02	0.45	0.65		0.77	0.6	0.42	0.08	0.97	0.46	0.79	-0.33	0.68	0.68	-0.93	0.91	-0.33
Property Plant Equipment	0.91	0.83	0.89	-0.82	0.75	0.83	-0.39	0.81	0.93	0.77		0.92	0.79	0.33	0.71	0.77	0.93	-0.75	0.94	0.21	-0.74	0.92	-0.75
Net Receivables	0.99	0.7	0.81	-0.73	0.85	0.97	-0.45	0.94	0.99	0.6	0.92		0.95	0.61	0.59	0.93	0.95	-0.91	0.99	0.11	-0.6	0.79	-0.91
Current Deferred Revenue	0.96	0.52	0.65	-0.6	0.88	1.0	-0.44	0.97	0.93	0.42	0.79	0.95		0.8	0.45	0.97	0.87	-0.95	0.92	0.06	-0.43	0.59	-0.95
Net Debt	0.64	0.16	0.27	-0.27	0.75	0.77	-0.14	0.74	0.59	0.08	0.33	0.61	0.8		0.21	0.78	0.56	-0.76	0.57	0.16	-0.15	0.12	-0.76
Long Term Debt Total	0.59	0.94	0.8	-0.77	0.5	0.52	0.03	0.47	0.63	0.97	0.71	0.59	0.45	0.21		0.47	0.8	-0.38	0.66	0.8	-0.88	0.81	-0.38
Capital Surpluse	0.94	0.52	0.65	-0.59	0.87	0.97	-0.42	0.94	0.91	0.46	0.77	0.93	0.97	0.78	0.47		0.86	-0.85	0.9	0.05	-0.47	0.62	-0.85
Net Invested Capital	0.96	0.86	0.9	-0.82	0.81	0.91	-0.28	0.87	0.96	0.79	0.93	0.95	0.87	0.56	0.8	0.86		-0.83	0.97	0.4	-0.77	0.87	-0.83
Short Long Term Debt	-0.91	-0.49	-0.62	0.58	-0.85	-0.95	0.41	-0.92	-0.89	-0.33	-0.75	-0.91	-0.95	-0.76	-0.38	-0.85	-0.83		-0.88	-0.06	0.38	-0.52	1.0
Net Working Capital	0.99	0.77	0.87	-0.77	0.81	0.95	-0.34	0.92	1.0	0.68	0.94	0.99	0.92	0.57	0.66	0.9	0.97	-0.88		0.19	-0.69	0.85	-0.88
Short Term Debt	0.14	0.62	0.4	-0.45	0.2	0.11	0.4	0.07	0.16	0.68	0.21	0.11	0.06	0.16	0.8	0.05	0.4	-0.06	0.19		-0.63	0.35	-0.06
Deferred Long Term Liab	-0.62	-0.91	-0.92	0.77	-0.47	-0.5	-0.21	-0.47	-0.67	-0.93	-0.74	-0.6	-0.43	-0.15	-0.88	-0.47	-0.77	0.38	-0.69	-0.63		-0.9	0.38
Capital Stock	0.78	0.92	0.95	-0.82	0.53	0.66	-0.13	0.63	0.83	0.91	0.92	0.79	0.59	0.12	0.81	0.62	0.87	-0.52	0.85	0.35	-0.9		-0.52
Intangible Assets	-0.91	-0.49	-0.62	0.58	-0.85	-0.95	0.41	-0.92	-0.89	-0.33	-0.75	-0.91	-0.95	-0.76	-0.38	-0.85	-0.83	1.0	-0.88	-0.06	0.38	-0.52

Click cells to compare fundamentals

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	4.22	4.43
Tangible Book Value Per Share	3.78	3.97

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC